Status:
UNKNOWN
Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy
Lead Sponsor:
Sherief Abd-Elsalam
Conditions:
Cirrhosis, Liver
Eligibility:
All Genders
45-65 years
Phase:
PHASE3
Brief Summary
propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy
Detailed Description
Effect of use of propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy, Randomised controlled trial.
Eligibility Criteria
Inclusion
- Liver cirrhosis
- presented to colonoscopy
Exclusion
- Encephalopathy
- Hypersensitivity
- Coagulopathy
Key Trial Info
Start Date :
April 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 11 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03388151
Start Date
April 1 2016
End Date
December 11 2022
Last Update
August 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sherief Abd-Elsalam
Tanta, Egypt